These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 29217458)
1. IMP2 and IMP3 cooperate to promote the metastasis of triple-negative breast cancer through destabilization of progesterone receptor. Kim HY; Ha Thi HT; Hong S Cancer Lett; 2018 Feb; 415():30-39. PubMed ID: 29217458 [TBL] [Abstract][Full Text] [Related]
2. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression. Guo GC; Wang JX; Han ML; Zhang LP; Li L Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302 [TBL] [Abstract][Full Text] [Related]
3. miR-365 inhibits cell invasion and migration of triple negative breast cancer through ADAM10. Liu F; Zhuang L; Wu R; Li D J BUON; 2019; 24(5):1905-1912. PubMed ID: 31786854 [TBL] [Abstract][Full Text] [Related]
4. IMP3 promotes TNBC stem cell property through miRNA-34a regulation. Huang QD; Zheng SR; Cai YJ; Chen DL; Shen YY; Lin CQ; Hu XQ; Wang XH; Shi H; Guo GL Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2688-2696. PubMed ID: 29771420 [TBL] [Abstract][Full Text] [Related]
5. EZH2 induces the expression of miR-1301 as a negative feedback control mechanism in triple negative breast cancer. Wu Q; Chen Z; Zhang G; Zhou W; Peng Y; Liu R; Chen C; Feng J Acta Biochim Biophys Sin (Shanghai); 2018 Jul; 50(7):693-700. PubMed ID: 29790898 [TBL] [Abstract][Full Text] [Related]
6. MiR-212-5p Suppresses the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer by Targeting Prrx2. Lv ZD; Yang DX; Liu XP; Jin LY; Wang XG; Yang ZC; Liu D; Zhao JJ; Kong B; Li FN; Wang HB Cell Physiol Biochem; 2017; 44(5):1785-1795. PubMed ID: 29216628 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1. Chen LL; Zhang ZJ; Yi ZB; Li JJ Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24. Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450 [TBL] [Abstract][Full Text] [Related]
9. Integrin α5 down-regulation by miR-205 suppresses triple negative breast cancer stemness and metastasis by inhibiting the Src/Vav2/Rac1 pathway. Xiao Y; Li Y; Tao H; Humphries B; Li A; Jiang Y; Yang C; Luo R; Wang Z Cancer Lett; 2018 Oct; 433():199-209. PubMed ID: 29964204 [TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor role of microRNA-1296 in triple-negative breast cancer. Phan B; Majid S; Ursu S; de Semir D; Nosrati M; Bezrookove V; Kashani-Sabet M; Dar AA Oncotarget; 2016 Apr; 7(15):19519-30. PubMed ID: 26799586 [TBL] [Abstract][Full Text] [Related]
11. DCAF13 promotes triple-negative breast cancer metastasis by mediating DTX3 mRNA degradation. Liu J; Li H; Mao A; Lu J; Liu W; Qie J; Pan G Cell Cycle; 2020 Dec; 19(24):3622-3631. PubMed ID: 33300431 [TBL] [Abstract][Full Text] [Related]
12. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer. Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269 [TBL] [Abstract][Full Text] [Related]
13. Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development. Jin C; Yan B; Lu Q; Lin Y; Ma L Tumour Biol; 2016 Jun; 37(6):7383-94. PubMed ID: 26676637 [TBL] [Abstract][Full Text] [Related]
14. miR-200a inhibits migration of triple-negative breast cancer cells through direct repression of the EPHA2 oncogene. Tsouko E; Wang J; Frigo DE; Aydoğdu E; Williams C Carcinogenesis; 2015 Sep; 36(9):1051-60. PubMed ID: 26088362 [TBL] [Abstract][Full Text] [Related]
15. Wnt pathway targeting reduces triple-negative breast cancer aggressiveness through miRNA regulation in vitro and in vivo. Mohammadi-Yeganeh S; Hosseini V; Paryan M J Cell Physiol; 2019 Aug; 234(10):18317-18328. PubMed ID: 30945294 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of IMP3 immunohistochemical expression in triple negative breast cancer. Sjekloča N; Tomić S; Mrklić I; Vukmirović F; Vučković L; Lovasić IB; Maras-Šimunić M Medicine (Baltimore); 2020 Feb; 99(7):e19091. PubMed ID: 32049813 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase. Bayraktar R; Pichler M; Kanlikilicer P; Ivan C; Bayraktar E; Kahraman N; Aslan B; Oguztuzun S; Ulasli M; Arslan A; Calin G; Lopez-Berestein G; Ozpolat B Oncotarget; 2017 Feb; 8(7):11641-11658. PubMed ID: 28036267 [TBL] [Abstract][Full Text] [Related]
18. Knockdown of long non-coding RNA TP73-AS1 suppresses triple negative breast cancer cell vasculogenic mimicry by targeting miR-490-3p/TWIST1 axis. Tao W; Sun W; Zhu H; Zhang J Biochem Biophys Res Commun; 2018 Oct; 504(4):629-634. PubMed ID: 30193732 [TBL] [Abstract][Full Text] [Related]
19. miR-136 suppresses tumor invasion and metastasis by targeting RASAL2 in triple-negative breast cancer. Yan M; Li X; Tong D; Han C; Zhao R; He Y; Jin X Oncol Rep; 2016 Jul; 36(1):65-71. PubMed ID: 27108696 [TBL] [Abstract][Full Text] [Related]
20. miR-221/222 activate the Wnt/β-catenin signaling to promote triple-negative breast cancer. Liu S; Wang Z; Liu Z; Shi S; Zhang Z; Zhang J; Lin H J Mol Cell Biol; 2018 Aug; 10(4):302-315. PubMed ID: 30053090 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]